Clinical trial

OPtimal Type 2 dIabetes Management Including Benchmarking and Standard trEatment.

NCT00681850

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2008-03-01

PhaseN/A

Study timeline

Study start (unknown)2008-03-01Date precision: month

Registry last updated2020-01-22

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Diabetesunresolved

Interventions

Sponsors & collaborators

AstraZenecalead sponsor

Mapped research locations

MadridSpain1 ValenciaSpain1 BrusselsBelgium1 AthensGreece1 GhentBelgium1 GlasgowUnited Kingdom1 LisbonPortugal1 ThessalonikiGreece1 LiègeBelgium1 A CoruñaSpain1 PortoPortugal1 ZaragozaSpain1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00681850 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.